UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007539
Receipt number R000008853
Scientific Title Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR Study
Date of disclosure of the study information 2012/04/01
Last modified on 2017/09/25 09:16:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR Study

Acronym

Remission induction by Raising the dose of Remicade in RA Extension study (RRRR-EX Study)

Scientific Title

Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR Study

Scientific Title:Acronym

Remission induction by Raising the dose of Remicade in RA Extension study (RRRR-EX Study)

Region

Japan


Condition

Condition

Rheumatoid Arthritis

Classification by specialty

Endocrinology and Metabolism Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate clinical remission in patients who continue treatment with IFX administration after failing to reach a clinical remission at 1 year treatment with IFX in RRRR Study

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Proportion of clinical remission 1 year after enrolling in RRRR-RX Study

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients who did not reach a clinical remission at the time of 54 weeks from first administration of IFX in RRRR Study
2)Patients who continue treatment with IFX administration after failing to reach a clinical remission
3)Written informed consent

Key exclusion criteria

1)Patients who discontinued IFX treatment prior to 54 week from the first administration of IFX in the RRRR Study
2) Patients who are inadequate to enter this trial due to the other reasons by physician's judgments

Target sample size

108


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiya Tanaka

Organization

University of Occupational and Environmental Health, Japan

Division name

The First Department of Internal Medicine, School of Medicine

Zip code


Address

1-1, Iseigaoka, Yahata-nishi-ku, Kitakyushu, Japan

TEL

093-603-1611

Email

tanaka@med.uoeh-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nao Horie

Organization

Hokkaido University Hospital

Division name

Translational Research and Clinical Trial Center

Zip code


Address

Nishi-5, Kita-14, Kita-ku, Sapporo, Hokkaido, Japan

TEL

011-706-7735

Homepage URL


Email

RRRR@pop.med.hokudai.ac.jp


Sponsor or person

Institute

University of Occupational and Environmental Health, Japan

Institute

Department

Personal name



Funding Source

Organization

A Research Grant-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan (partly), Self funding

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

産業医科大学(福岡県)
医療法人早石会早石病院(大阪府)
東京医科歯科大学(東京都)
長崎大学病院(長崎県)
東北大学病院(宮城県)
埼玉医科大学総合医療センター(埼玉県)
医療法人社団善仁会市民の森病院(宮崎県)
埼玉医科大学(埼玉県)
香川大学医学部(香川県)
財団法人天理よろづ相談所病院(奈良県)
横浜市立みなと赤十字病院(神奈川県)
青森県立中央病院(青森県)
名古屋大学医学部(愛知県)
牛尾整形外科(大阪府)
北海道大学病院(北海道)
久留米大学医療センター(福岡県)
順天堂大学医学部(東京都)
慶應義塾大学医学部(東京都)
京都大学医学部附属病院京都府)
松原メイフラワー病院(兵庫県)
医療法人社団順和会 京都下鴨病院(京都府)
日本赤十字社大阪赤十字病院(大阪府)
医療法人財団白十字会 佐世保中央病院(長崎県)
兵庫医科大学(兵庫県)
北里大学病院(東京都)
医療法人社団 協志会宇多津浜クリニック(香川県)
関西医科大学附属枚方病院(大阪府)
日本赤十字社松山赤十字病院(愛媛県)


Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2015 Year 11 Month 30 Day

Date of closure to data entry

2017 Year 10 Month 31 Day

Date trial data considered complete

2017 Year 11 Month 30 Day

Date analysis concluded

2018 Year 06 Month 30 Day


Other

Other related information

prospective observational study


Management information

Registered date

2012 Year 03 Month 21 Day

Last modified on

2017 Year 09 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008853


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name